Today's Change
-6.68%
AI Sentiment
55%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is down 6.68% today with neutral sentiment across 5 recent news articles. Top movers include $FCX (-6.92%), $EMN (-3.73%).
Bullish Factors
- Predominantly positive news flow
Risk Factors
- No strong bearish signals detected
Stocks in Materials
2 stocksMaterials News
926 articles
Benzinga89d ago
OLAPLEX, a Leading, Science-Led Prestige Hair Care Brand, to be Acquired by Henkel for $1.4 Billion
GlobeNewswire Inc.89d ago
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
GlobeNewswire Inc.89d ago
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
GlobeNewswire Inc.89d ago
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
GlobeNewswire Inc.89d ago
Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE
GlobeNewswire Inc.89d ago
ALDX Investor News: If You Have Suffered Losses in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Motley Fool89d ago
Palvella Stock Up 340% as Insider Sells Shares. Here's What the Move Does (And Does Not) Signal
Benzinga89d ago
Securities Fraud Investigation Into Coty Inc. (COTY) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Motley Fool89d ago
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now
GlobeNewswire Inc.89d ago
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
GlobeNewswire Inc.89d ago
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
Market Sentiment
Neutral
55% Sentiment Score
Sector Stats
Total Stocks2
News Today5
Avg Volume9.5M
AI SentimentNeutral